Bio-Works Technologies AB (publ) (NGM:BIOWKS)
Sweden · Delayed Price · Currency is SEK 3.630
-0.300 (-7.63%)
At close: Jun 9, 2026
Bio-Works Technologies AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 82.85 | 62.5 | 25.47 | 43.9 | 41.32 | 21.91 |
Other Revenue | 0.38 | - | 5.02 | - | - | 34.45 |
| 83.23 | 62.5 | 30.49 | 43.9 | 41.32 | 56.36 | |
Revenue Growth (YoY) | 153.59% | 105.02% | -30.55% | 6.23% | -26.68% | 679.09% |
Cost of Revenue | 20.71 | 14.7 | 5.45 | 17.08 | 12.47 | 3.35 |
Gross Profit | 62.52 | 47.8 | 25.04 | 26.82 | 28.85 | 53.01 |
Selling, General & Admin | 66.86 | 64.22 | 63.2 | 81.63 | 74.95 | 62.5 |
Other Operating Expenses | 1.26 | 1.19 | 0.12 | 2.09 | 0.57 | 0.76 |
Operating Expenses | 68.63 | 65.92 | 63.83 | 84.33 | 75.99 | 63.97 |
Operating Income | -6.11 | -18.12 | -38.8 | -57.5 | -47.14 | -10.96 |
Interest Expense | -0 | -0 | -0.01 | -0 | -0.02 | -0.02 |
Interest & Investment Income | 0.57 | 0.55 | 0.6 | 0.88 | 0.35 | 0.07 |
Currency Exchange Gain (Loss) | 0.41 | 0.41 | 0.93 | 1.89 | 2.12 | 1.53 |
Other Non Operating Income (Expenses) | 0.63 | -0 | -0 | - | 0 | - |
EBT Excluding Unusual Items | -4.5 | -17.16 | -37.28 | -54.73 | -44.7 | -9.37 |
Pretax Income | -4.5 | -17.16 | -37.28 | -54.73 | -44.7 | -9.37 |
Income Tax Expense | -1.9 | -1.92 | 0.08 | 2.09 | 0.26 | 3.57 |
Net Income | -2.59 | -15.25 | -37.36 | -56.82 | -44.95 | -12.94 |
Net Income to Common | -2.59 | -15.25 | -37.36 | -56.82 | -44.95 | -12.94 |
Shares Outstanding (Basic) | 86 | 83 | 50 | 36 | 35 | 31 |
Shares Outstanding (Diluted) | 86 | 83 | 50 | 36 | 35 | 31 |
Shares Change (YoY) | 43.33% | 65.69% | 38.31% | 3.16% | 12.17% | 2.60% |
EPS (Basic) | -0.03 | -0.18 | -0.75 | -1.57 | -1.28 | -0.41 |
EPS (Diluted) | -0.03 | -0.18 | -0.75 | -1.57 | -1.28 | -0.41 |
Free Cash Flow | -9.6 | -19.22 | -43.18 | -59.85 | -41 | -14.31 |
Free Cash Flow Per Share | -0.11 | -0.23 | -0.86 | -1.66 | -1.17 | -0.46 |
Gross Margin | 75.12% | 76.48% | 82.13% | 61.10% | 69.81% | 94.06% |
Operating Margin | -7.34% | -28.99% | -127.26% | -131.00% | -114.09% | -19.44% |
Profit Margin | -3.12% | -24.39% | -122.54% | -129.45% | -108.78% | -22.96% |
Free Cash Flow Margin | -11.54% | -30.74% | -141.63% | -136.34% | -99.23% | -25.39% |
EBITDA | -5.6 | -17.61 | -38.28 | -56.89 | -46.67 | -10.47 |
EBITDA Margin | -6.73% | -28.17% | -125.57% | -129.61% | -112.95% | -18.57% |
D&A For EBITDA | 0.51 | 0.51 | 0.51 | 0.61 | 0.47 | 0.49 |
EBIT | -6.11 | -18.12 | -38.8 | -57.5 | -47.14 | -10.96 |
EBIT Margin | -7.34% | -28.99% | -127.26% | -131.00% | -114.09% | -19.44% |
Revenue as Reported | 83.91 | 62.91 | 32.94 | 46.7 | 43.01 | 58.82 |